In today’s session Perrigo Company plc Ordinary Shares (PRGO) registered an unusually high (1,070) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the November, 2016 call, expecting serious PRGO increase. With 1,070 contracts traded and 3994 open interest for the Nov, 16 contract, it seems this is a quite bullish bet. The option with symbol: PRGO161118C00115000 closed last at: $1.25 or 108.3% up. About 374,320 shares traded hands. Perrigo Company plc Ordinary Shares (NYSE:PRGO) has declined 25.23% since March 2, 2016 and is downtrending. It has underperformed by 33.49% the S&P500.
Analysts await Perrigo Company plc Ordinary Shares (NYSE:PRGO) to report earnings on October, 27. They expect $1.85 EPS, up 5.11% or $0.09 from last year’s $1.76 per share. PRGO’s profit will be $259.85 million for 12.97 P/E if the $1.85 EPS becomes a reality. After $1.93 actual EPS reported by Perrigo Company plc Ordinary Shares for the previous quarter, Wall Street now forecasts -4.15% negative EPS growth.
Perrigo Company plc Ordinary Shares (NYSE:PRGO) Ratings Coverage
Out of 14 analysts covering Perrigo Company Plc (NYSE:PRGO), 4 rate it a “Buy”, 1 “Sell”, while 9 “Hold”. This means 29% are positive. $241 is the highest target while $84 is the lowest. The $132.91 average target is 38.49% above today’s ($95.97) stock price. Perrigo Company Plc has been the topic of 33 analyst reports since October 23, 2015 according to StockzIntelligence Inc. The firm has “Neutral” rating given on Tuesday, April 26 by JP Morgan. The stock has “Buy” rating given by Deutsche Bank on Friday, October 23. The stock of Perrigo Company plc Ordinary Shares (NYSE:PRGO) earned “Equal-Weight” rating by Morgan Stanley on Thursday, December 3. As per Monday, April 25, the company rating was downgraded by Wells Fargo. The company was downgraded on Tuesday, April 26 by Jefferies. As per Thursday, December 10, the company rating was upgraded by Argus Research. The stock has “Buy” rating given by B. Riley & Co on Tuesday, November 24. The firm has “Outperform” rating given on Friday, February 19 by Wells Fargo. The firm earned “Neutral” rating on Thursday, August 11 by JP Morgan. The company was maintained on Wednesday, April 6 by Argus Research.
According to Zacks Investment Research, “Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.”
Insitutional Activity: The institutional sentiment decreased to 0.81 in Q2 2016. Its down 0.38, from 1.19 in 2016Q1. The ratio worsened, as 103 funds sold all Perrigo Company plc Ordinary Shares shares owned while 175 reduced positions. 80 funds bought stakes while 146 increased positions. They now own 96.70 million shares or 9.76% less from 107.16 million shares in 2016Q1.
Endurant Mgmt L P, a California-based fund reported 7,600 shares. Assetmark last reported 578 shares in the company. Moreover, Adage Cap Prtn Group Ltd Liability Company has 0.03% invested in Perrigo Company plc Ordinary Shares (NYSE:PRGO) for 117,804 shares. Mycio Wealth Partners Ltd Com accumulated 29 shares or 0% of the stock. Nordea Invest Mngmt Ab has invested 0.36% of its portfolio in Perrigo Company plc Ordinary Shares (NYSE:PRGO). Parametric Port Assoc Limited Liability Corp last reported 137,964 shares in the company. Moreover, Engineers Gate Manager L P has 0.17% invested in Perrigo Company plc Ordinary Shares (NYSE:PRGO) for 26,300 shares. Spot Trading Limited Co holds 2,503 shares or 0% of its portfolio. Ladenburg Thalmann Fincl Svcs Inc, a Florida-based fund reported 1,268 shares. Cibc Asset Mgmt last reported 10,759 shares in the company. Moreover, Gargoyle Advisor Ltd Limited Liability Company has 0.18% invested in Perrigo Company plc Ordinary Shares (NYSE:PRGO) for 5,166 shares. Eaton Vance Management has 10,169 shares for 0% of their US portfolio. Financial Architects holds 0% or 27 shares in its portfolio. Pnc Services Group Incorporated owns 9,917 shares or 0% of their US portfolio. Moreover, Guardian Life Ins Of America has 0% invested in Perrigo Company plc Ordinary Shares (NYSE:PRGO) for 542 shares.
PRGO Company Profile
Perrigo Company plc (Perrigo), formerly Perrigo Company Limited, incorporated on June 28, 2013, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company’s divisions include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences and Other. The Firm makes OTC healthcare products and supplies infant formulas for the store brand market. It is also a well-known provider of generic extended topical prescription products. It provides healthcare products across a range of product categories and geographies, primarily in North America, Europe and Australia, as well as in other markets, including Israel and China.
More important recent Perrigo Company plc Ordinary Shares (NYSE:PRGO) news were published by: Fool.com which released: “Why Perrigo Company PLC Ordinary Shares Are Dropping Today” on April 25, 2016, also Fool.com published article titled: “Why Perrigo Company PLC Ordinary Shares Are Plummeting Today”, Investorplace.com published: “Why KLA-Tencor Corp (KLAC), Perrigo Company plc Ordinary Shares (PRGO) and …” on August 10, 2016. More interesting news about Perrigo Company plc Ordinary Shares (NYSE:PRGO) was released by: Investorplace.com and their article: “3 Stocks to Watch Monday: Tesla Motors Inc (TSLA), Perrigo Company plc …” with publication date: September 12, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.